Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First, is scheduled to end on July 31st. Learn about your options to continue receiving care at Temple Health.
Fox Chase Cancer Center and the Lewis Katz School of Medicine at Temple University Welcome Dr. Akina Tamaki
PHILADELPHIA (July 12, 2024) — Fox Chase Cancer Center and the Lewis Katz School of Medicine at Temple University are pleased to announce the hiring of Akina Tamaki, MD, FACS, as an Associate Professor in the Department of Otolaryngology – Head and Neck Surgery at the Katz School of Medicine.
Tamaki is joining the Fox Chase and Temple Head and Neck Cancer Programs from the Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, where she served as an Associate Professor and Associate Residency Program Director. She brings a breadth of experience in mucosal surgery, endocrine surgery, microvascular reconstruction, and transoral robotic surgery.
Tamaki earned her medical degree from the University of Maryland School of Medicine. She completed an otolaryngology residency at Case Western Reserve University, University Hospitals Cleveland Medical Center. She then completed a fellowship in head and neck oncologic surgery and microvascular surgery at Ohio State University.
Throughout her career, Tamaki has served as a peer reviewer for 13 medical journals and has delivered over 40 invited lectures. She has also contributed to over 60 peer-reviewed publications, two book chapters, and nearly 30 abstracts and posters. Her work covers a wide range of topics, including oncologic and reconstructive head and neck surgery.
Tamaki was nominated by her peers to the 2023 and 2024 Best Doctors list in Cleveland Magazine. She is a member of several professional organizations, including the American Academy of Otolaryngology – Head and Neck Surgery, Alpha Omega Alpha Honor Medical Society, and the American Head and Neck Society.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427